Quantcast

Penn Researchers, Diplomat study shows: Nearly 50% Medicaid hepatitis C patients denied therapies as not considered “a medical necessity”

Nearly 50 percent of Medicaid patients infected with chronic hepatitis C virus (HCV) whose doctors had prescribed newer, life-saving antiviral drugs were denied coverage to the therapies because they were not considered “a medical necessity.”

Read more